Last reviewed · How we verify
NCT07521540
Integrated Rehabilitation in HDU for Post-Intensive Care SyndromeLiberation in Patients With PICS
NA trial testing Integrated Multidisciplinary Rehabilitation in Post-Intensive Care Syndrome (PICS) in 250 participants. Not yet recruiting.
31 October 2027
Quick facts
| Lead sponsor | Hongying Jiang, MD |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 250 |
| Start date | 1 April 2026 |
| Primary completion | 31 October 2027 |
| Estimated completion | 31 December 2027 |
| Sites | 1 location across China |
Drugs / interventions tested
- Integrated Multidisciplinary Rehabilitation
Conditions studied
- Post-Intensive Care Syndrome (PICS) — all drugs for Post-Intensive Care Syndrome (PICS) →
- Critical Illness Recovery — all drugs for Critical Illness Recovery →
- Mechanical Ventilation — all drugs for Mechanical Ventilation →
Sponsor
Hongying Jiang, MD
Who can join
18 and older, any sex, with Post-Intensive Care Syndrome (PICS) or Critical Illness Recovery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Post-intensive care syndrome (PICS) is characterized by persistent physical, cognitive, and psychological impairments among survivors of critical illness. Although advances in intensive care medicine have reduced mortality, a large proportion of ICU survivors experience long-term functional impairments after discharge. High-dependency units (HDUs) serve as transitional care settings between intensive care units and general wards. Many critically ill survivors who cannot directly return home are transferred to HDU for continued treatment and rehabilitation. However, evidence regarding systematic multidisciplinary rehabilitation interventions in HDU settings remains limited. This prospective single-center interventional study aims to evaluate the effects of an integrated multidisciplinary rehabilitation model implemented in the HDU on physical, cognitive, and psychological outcomes among patients with post-intensive care syndrome. All enrolled patients will receive standardized integrated medical, nursing, and rehabilitation interventions. Multidimensional functional assessments will be conducted at baseline, during hospitalization, and before discharge from the HDU.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07521540
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Post-Intensive Care Syndrome (PICS)
Currently open trials in the same condition.
- NCT07170527 — Long-Term Outcomes and Post-Intensive Care Syndrome: Investigating the Associations Between Metabolic Signatures and Phy · recruiting
- NCT07035106 — I-WEAR: Evaluating Wearables and Health Summaries in ICU Survivors · NA · recruiting
Other Hongying Jiang, MD trials
Trials by the same sponsor.
- NCT07435727 — Comparison of Speaking Valve Trial and Capping Trial for Tracheostomy Decannulation in Stroke Patients · NA · not yet recruiting
- NCT07183670 — Standardized Tracheostomy Decannulation Protocol for Patients With Prolonged Disorders of Consciousness · enrolling by invitation
- NCT07173634 — Speaking Valve Trial vs. Capping Trial for Tracheostomy Decannulation in Prolonged Disorders of Consciousness · NA · enrolling by invitation
- NCT07317791 — Cough Flow as a Criterion Decannulation Threshold in Prolonged Tracheostomy Patients · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07521540 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hongying Jiang, MD
- Last refreshed: 13 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07521540.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing